Relapse of multiresistant Salmonella typhi after combined therapy with ciprofloxacin and ceftriaxone [1]

Clinical Microbiology and Infection

Volumn 6, Issue 3, 2000, Pages 167-

  Dragsted, U B ^a   Pedersen, P ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; GREPAFLOXACIN; NALIDIXIC ACID; QUINOLONE DERIVATIVE; TROVAFLOXACIN;

ANTIBIOTIC RESISTANCE; BLOOD CULTURE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG CHOICE; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; LETTER; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; PLASMID; PRIORITY JOURNAL; RELAPSE; SALMONELLA TYPHI; SCHOOL CHILD; TREATMENT FAILURE; TYPHOID FEVER;

SALMONELLA; SALMONELLA TYPHI;

EID: 0034160369     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2000.00036.x     Document Type: Letter

References (5)

1. Ciprofloxacin versus ceftriaxone in the treatment of multiresistant typhoid fever
2. Resistance to ciprofloxacin in pathogenic Enterobacteriaceae in England and Wales in 1996
3. Epidemic ciprofloxacin-resistant Salmonella typhi in Tajikistan
4. Quinolone resistance from a transferable plasmid
5. Multidrug-resistant Salmonella typhi: A worldwide epidemic